Computed Tomography Angiography, Magnetic Resonance Angiography, Angiography, Venography, Intravascular Ultrasound, and Radiation Safety

8.1Principles of modality selection

Modality selection aligns with the intended clinical decision rather than scanner availability. In peripheral artery disease (PAD), imaging is reserved for patients in whom revascularization is contemplated, symptoms progress despite guideline-directed therapy, or unresolved diagnostic questions remain. Routine anatomic imaging is not indicated for asymptomatic PAD or stable intermittent claudication responding to medical and exercise therapy ESVS 2024 · ESC 2017. When revascularization is planned, advanced anatomic imaging is interpreted in the context of symptoms, wounds, and physiologic testing ACC/AHA PAD 2024.

For aortic disease, diagnosis and surveillance rely on consistent anatomic landmarks, acquisition techniques, and reporting across computed tomography (CT), magnetic resonance imaging (MRI), and echocardiography to enable reliable interpretation of interval growth and post-intervention change ACC/AHA Aortic Disease 2022.

8.2Diagnostic modalities and indications

Each imaging modality occupies a defined role in the diagnostic and therapeutic pathway:

• Duplex ultrasound: Serves as the first-line anatomic-hemodynamic test for diagnosing PAD and localizing lesions when local laboratory quality is reliable ACR Appropriateness Criteria 2022. It is the standard initial modality for abdominal aortic aneurysm (AAA) screening, demonstrating 94% to 100% sensitivity and 98% to 100% specificity for AAA detection, and conferring a population-level mortality benefit in men aged 65 to 74 years USPSTF 2019 · Ashton et al. (2002). USPSTF 2019 recommends one-time screening ultrasonography for AAA in men aged 65 to 75 who have ever smoked (Grade B) and selectively offering screening to men 65 to 75 who have never smoked (Grade C). Complementary implementation evidence comes from Sweden’s nationwide program: 302,957 men aged 65 years were invited, 84% attended, and screening introduction was associated with declining AAA-specific mortality. This observational program evaluation is not a randomized trial and does not independently establish an all-cause mortality benefit or the USPSTF eligibility criteria Outcome 2016. Limitations include body habitus, bowel gas, severe arterial calcification, and multilevel disease.
• Computed tomography angiography (CTA): Functions as the primary modality for broad anatomic mapping and revascularization planning. It defines inflow, outflow, access vessels, prior interventions, and calcification ACR Appropriateness Criteria 2022. Efficacy is degraded by severe calcification, while risk profiles include iodinated contrast and ionizing radiation exposure.
• Magnetic resonance angiography (MRA): Provides a zero-ionizing-radiation alternative for lower-extremity vascular imaging, particularly favored in young patients, those requiring repeated imaging, or those with renal impairment ACR Appropriateness Criteria 2022. Image quality is limited by stent artifact, severe calcification, motion, and claustrophobia. Safety relies on strict magnetic resonance environment screening for implants and devices ACR MR Safety Manual · 2024.
• Digital subtraction angiography (DSA) and venography: Reserved primarily for therapeutic encounters in which endovascular intervention is planned or when noninvasive imaging is inconclusive ACR Appropriateness Criteria 2022 · CREST (2010). Diagnostic-only angiography is unusual and carries procedural risk, contrast burden, and operator-dependent radiation exposure.
• Intravascular ultrasound (IVUS): Provides intraprocedural cross-sectional assessment during peripheral arterial and deep venous intervention, complementing angiography for lesion dimensions, treatment planning, and assessment of the treated segment. The 2024 multisociety expert opinion addresses these peripheral arterial/deep venous applications; it should not be cited as proof of routine IVUS benefit for every EVAR or TEVAR procedure. IVUS does not provide the same global anatomical overview as preoperative cross-sectional imaging Secemsky 2024.

8.3Imaging pathways and interpretation thresholds

Thoracic aortic CTA or MRA requires standardized inner-edge-to-inner-edge ECG-synchronized measurements, using outer-edge measurements when wall abnormalities are present ACC/AHA Aortic Disease 2022. Late post-EVAR imaging is indicated to identify device-related failure or anatomy requiring reintervention, guided by 15-year outcomes demonstrating late rupture and reintervention risks Patel et al. (2016). Baseline contrast CTA is obtained within the first month after EVAR; if no endoleak or sac enlargement is present, surveillance moves to color duplex ultrasound (with or without contrast CT) at 12 months and annually thereafter, whereas a detected endoleak or sac growth shortens imaging to roughly 6-month intervals and prompts review for reintervention SVS 2018.

Standardized thresholds govern disease grading and intervention triggers. In lower-extremity arterial duplex, peak systolic velocity (PSV) and peak systolic velocity ratios (PSVR) assign stenosis severity, though heavy calcification and multilevel disease can elevate velocities independently of true critical stenosis AUC Peripheral Vascular Ultrasound 2012.

8.4Contrast and magnetic resonance safety

Iodinated contrast administration requires pre-procedural risk assessment, hydration planning, and acute reaction-response systems encompassing allergic-like and physiologic reactions ACR Contrast Manual · 2025. Consider premedication after a same-class allergic-like or unknown reaction, balancing delay against urgency. ACR oral options are prednisone 50 mg at 13, 7 and 1 hours, or methylprednisolone 32 mg at 12 and 2 hours before contrast. Diphenhydramine 50 mg one hour beforehand is optional. An accelerated IV option uses methylprednisolone 40 mg or hydrocortisone 200 mg immediately and every four hours until contrast, with diphenhydramine 50 mg IV one hour beforehand. Shorter-than-4–5-hour regimens lack efficacy evidence; prophylaxis cannot eliminate reactions ACR 2026. Post-contrast acute kidney injury (AKI) is monitored using Kidney Disease: Improving Global Outcomes (KDIGO) Stage 1 criteria, which trigger early review of volume status, hemodynamics, and nephrotoxic medications.

Magnetic resonance safety operates as an institutional workflow rather than a point-of-care checklist. Safe MRA requires zone-based environment control, structured screening for implants and devices, staff role definitions, and management of static magnetic field, gradient, and radiofrequency hazards ACR MR Safety Manual · 2024.

Gadolinium-based agents carry a risk of nephrogenic systemic fibrosis in advanced renal impairment (eGFR < 30 mL/min/1.73 m^2); group II agents (a risk category that is not synonymous with macrocyclic structure) are preferred and given at the lowest dose adequate for diagnosis ACR Contrast Manual · 2025 · ACR MR Safety Manual · 2024 · KDIGO 2012. In pregnancy, gadolinium requires critical benefit outweighing uncertain fetal risk. Breastfeeding need not routinely stop after iodinated or gadolinium contrast; support informed maternal choice ACR 2026.

8.5Radiation stewardship

CTA and fluoroscopically guided interventions (angiography, venography) deliver moderate-to-high relative radiation doses. Operators employ the As Low As Reasonably Achievable (ALARA) principle by tailoring protocols to patient size, using non-ionizing alternatives (such as ultrasound or MRA) when appropriate, and documenting exposure parameters including dose-length product, dose-area product, and fluoroscopy time ACR Appropriateness Criteria 2022. Vascular-specific radiation protection is addressed by the ESVS 2023 Clinical Practice Guidelines on Radiation Safety, alongside international radiation-protection frameworks and institutional monitoring arrangements ACR Radiation Safety · ESVS 2023 · ICRP 103 · 2007.

8.6Areas of controversy

The 2024 multisociety IVUS document is expert opinion on peripheral arterial and deep venous intervention. It identifies diagnostic and procedural applications but also evidence and standardization gaps; it is not proof that routine IVUS improves every clinical endpoint or that its conclusions transfer unchanged to aortic endografting Secemsky 2024. The 2012 peripheral vascular ultrasound appropriate-use criteria remain historical guidance for selecting noninvasive examinations, not an IVUS efficacy source AUC Peripheral Vascular Ultrasound 2012.

Duplex velocity thresholds for lower-extremity stenosis grading are not uniformly established. Heavy calcification and tandem lesions alter peak systolic velocity independently of true critical stenosis, requiring individual laboratory validation rather than unadjusted reliance on society-published numeric cutoffs AUC Peripheral Vascular Ultrasound 2012. Furthermore, detailed reporting formats and specific post-imaging surveillance intervals lack uniform standardization and remain heavily dependent on local protocols and variations in disease type. Diameter-based surveillance of unrepaired AAA is standardized and should be distinguished from post-EVAR surveillance. ESVS 2024 advises considering ultrasound every three years for 30–39 mm aneurysms in both sexes, annually for men with 40–49 mm aneurysms and women with 40–44 mm aneurysms, and every six months for men at or above 50 mm and women at or above 45 mm. These are recommendations IIa, B for men and IIa, C for women, interpreted with life expectancy, suitability for eventual repair, and preferences ESVS 2024. ESVS 2019 and SVS 2018 remain identifiable historical comparators, rather than being relabeled as 2024 sources ESVS 2019 · SVS 2018.

Further reading

• Advancements in imaging for endovascular treatment of peripheral artery disease. (2026). PAD duplex, CTA and MRA applications and limitations; does not cover every venous or radiation-safety question. Advancements imaging 2026